2355. Clinically vs. Serologically Identified Varicella: A Hidden Infection Burden. Lessons of 10-Year Follow-up in Varicella Endemic Countries

por Gillard, Paul, Povey, Michael, Carryn, Stephane
Publicado 2018

Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries

por Gillard, Paul, Povey, Michael, Carryn, Stephane
Publicado 2021

Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study

por Gillard, Paul, Giet, Didier, Heijmans, Stéphane, Dramé, Mamadou, Walravens, Karl, Roman, François
Publicado 2014

A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses

por Baras, Benoit, Bouveret, Nancy, Devaster, Jeanne‐Marie, Fries, Louis, Gillard, Paul, Sänger, Roland, Hanon, Emmanuel
Publicado 2008

Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates

por Ravault, Stéphanie, Friel, Damien, Di Paolo, Emmanuel, Caplanusi, Adrian, Gillard, Paul, Povey, Michael, Carryn, Stephane
Publicado 2019

Flexibility of interval between vaccinations with AS03(A)-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18–60 and >60 years: a randomized trial

por Duval, Xavier, Caplanusi, Adrian, Laurichesse, Henri, Deplanque, Dominique, Loulergue, Pierre, Vaman, Tejaswini, Launay, Odile, Gillard, Paul
Publicado 2012

An assessment of prime‐boost vaccination schedules with AS03(A)‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults

por Gillard, Paul, Caplanusi, Adrian, Knuf, Markus, Roman, François, Walravens, Karl, Moris, Philippe, Dramé, Mamadou, Schwarz, Tino F.
Publicado 2012

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults

por Ikematsu, Hideyuki, Nagai, Hideaki, Kawashima, Masahiro, Kawakami, Yasunobu, Tenjinbaru, Kazuyoshi, Li, Ping, Walravens, Karl, Gillard, Paul, Roman, François
Publicado 2012

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japane...

por Gillard, Paul, Tamura, Tsuyoshi, Kuroki, Haruo, Morikawa, Yoshiyuki, Moerman, Leentje, Parra, Jose, Kitamura, Yurina, Mihara, Kazuko, Okamasa, Arisa
Publicado 2019

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses

por Coccia, Margherita, Burny, Wivine, Demoitié, Marie-Ange, Gillard, Paul, van den Berg, Robert A., van der Most, Robbert
Publicado 2022

Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03(A)-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial

por Heijmans, Stéphane, De Meulemeester, Marc, Reynders, Paul, Giet, Didier, Demanet, Etienne, Devresse, Pierre-Yves, Icardi, Giancarlo, Dramé, Mamadou, Roman, François, Gillard, Paul
Publicado 2011

Long-term booster schedules with AS03(A)-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults

por Gillard, Paul, Chu, Daniel Wai Sing, Hwang, Shinn-Jang, Yang, Pan-Chyr, Thongcharoen, Prasert, Lim, Fong Seng, Dramé, Mamadou, Walravens, Karl, Roman, François
Publicado 2014

Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Va...

por van den Berg, Robert A., De Mot, Laurane, Leroux-Roels, Geert, Bechtold, Viviane, Clement, Frédéric, Coccia, Margherita, Jongert, Erik, Evans, Thomas G., Gillard, Paul, van der Most, Robbert G.
Publicado 2018

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, childr...

por Garcia-Sicilia, José, Arístegui, Javier, Omeñaca, Félix, Carmona, Alfonso, Tejedor, Juan C, Merino, José M, García-Corbeira, Pilar, Walravens, Karl, Bambure, Vinod, Moris, Philippe, Caplanusi, Adrian, Gillard, Paul, Dieussaert, Ilse
Publicado 2015

RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study

por Lucidarme, Olivier, Wagner, Mathilde, Gillard, Paul, Kim, Stefano, Bachet, Jean-Baptiste, Rousseau, Benoit, Mazard, Thibault, Louvet, Christophe, Chibaudel, Benoist, Cohen, Romain, Garcia-Larnicol, Marie-Line, Gobert, Aurelien, Henriques, Julie, André, Thierry
Publicado 2019

Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistenc...

por Díez-Domingo, Javier, Baldó, José-María, Planelles-Catarino, Maria Victoria, Garcés-Sánchez, María, Ubeda, Isabel, Jubert–Rosich, Angels, Marès, Josep, Garcia-Corbeira, Pilar, Moris, Philippe, Teko, Maurice, Vanden Abeele, Carline, Gillard, Paul
Publicado 2015

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: result...

por Launay, Odile, Duval, Xavier, Fitoussi, Serge, Jilg, Wolfgang, Kerdpanich, Angkool, Montellano, May, Schwarz, Tino F, Watanveerade, Veerachai, Wenzel, Jürgen J, Zalcman, Gerard, Bambure, Vinod, Li, Ping, Caplanusi, Adrian, Madan, Anuradha, Gillard, Paul, Vaughn, David W
Publicado 2013

Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-...

por Faust, Saul N., Le Roy, Maguelone, Pancharoen, Chitsanu, Weber, Miguel Angel Rodriguez, Cathie, Katrina, Behre, Ulrich, Bernatoniene, Jolanta, Snape, Matthew D., Helm, Klaus, Medina Pech, Carlos Eduardo, Henry, Ouzama, Baccarini, Carmen, Povey, Michael, Gillard, Paul
Publicado 2019

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Cons...

por Klein, Nicola P, Abu-Elyazeed, Remon, Povey, Michael, Macias Parra, Mercedes, Diez-Domingo, Javier, Ahonen, Anitta, Korhonen, Tiina, Tinoco, Juan-Carlos, Weiner, Leonard, Marshall, Gary S, Silas, Peter E, Sarpong, Kwabena O, Ramsey, Keith P, Fling, John A, Speicher, David, Campos, Maribel, Munjal, Iona, Peltier, Christopher, Vesikari, Timo, Baccarini, Carmen, Caplanusi, Adrian, Gillard, Paul, Carryn, Stephane, Henry, Ouzama
Publicado 2019

Phase 2b placebo-controlled trial of M72/AS01(E) candidate vaccine to prevent active tuberculosis in adults

por Van Der Meeren, Olivier, Hatherill, Mark, Nduba, Videlis, Wilkinson, Robert J, Muyoyeta, Monde, Van Brakel, Elana, Ayles, Helen M, Henostroza, German, Thienemann, Friedrich, Scriba, Thomas J., Diacon, Andreas, Blatner, Gretta L., Demoitié, Marie-Ange, Tameris, Michele, Malahleha, Mookho, Innes, James C., Hellstrom, Elizabeth, Martinson, Neil, Singh, Tina, Akite, Elaine Jacqueline, Khatoon, Aisha, Bollaerts, Anne, Ginsberg, Ann M., Evans, Thomas G., Gillard, Paul, Tait, Dereck R.
Publicado 2018